Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dyspnoea III – Pulmonary oedema

Similar presentations


Presentation on theme: "Dyspnoea III – Pulmonary oedema"— Presentation transcript:

1 Dyspnoea III – Pulmonary oedema
EMC SDMH 2015

2 Define the pulmonary oedema syndrome and understand differing aetiologies
Recognise predisposing and precipitating factors in cardiogenic pulmonary oedema Outline ED treatment modalities Objectives

3 Pulmonary oedema = fluid translocation into alveolar air spaces due to changes in pulmonary capillary properties Due to either altered capillary permeability(‘leakiness’) Altered transmembrane pressure gradient Two distinct groups – High (>20mmHg) pulmonary capillary pressure (‘Cardiogenic’) Low (<20mmHg) pulmonary capillary pressure (‘Non-cardiogenic’) Pathophysiology

4 Cardiogenic pulmonary oedema
Progressive, accelerating cycle Accumulation of fluids alveolar collapse loss of lung capacity(FRC) increased work of breathing to inflate ‘waterlogged’ lung Cardiogenic pulmonary oedema

5 Cardiogenic pulmonary oedema = syndrome of ‘transient’ LV failure
WHY does this individual have cardiogenic pulmonary oedema? ~40-60% will have normal LVEF; not oedematous NOT synonymous with ‘CHF’ Raises concept of ‘diastolic’ vs ‘systolic’ LV failure Cardiac failure?

6 Systolic/Diastolic failure

7 Other acute causes APO may have several other acute causes
-’Pump failure’ - Valve failure RVF in isolation (eg chronic pulmonary disease) does not cause APO Overlaps possible Other acute causes

8 Precipitants Frequently an acute triggering event Coronary event
Needs to be sought and corrected if possible Mnemonic – ‘CHIVE MAN’ Coronary event Hypertensive episode Infection Volume overload/Valve Embolism Medication changes Arrhythmia(AF) Non-compliance Precipitants

9 Management Principles of treatment -Reverse hypoxia -Reduce WoB
-Decrease SVR -Improve cardiac output -Seek and remove triggering factors Management

10 Breathing High flow O2 to keep Sats >95% NIPPV as soon as available
PEEP recruits collapsed alveoli Reduces WoB and restores FRC with each breath cycle CPAP/BiPAP equally efficacious at reducing need for intubation Potential for hypotension 10-30% mask intolerance Breathing

11 Circulation Aim to reduce preload and afterload to assist failing LV
PEEP reduces both by instituting intra-thoracic pressure Effect can be increased by use of nitrates GTN SL or by infusion. GTN 600mcg SL q 5 equivalent to 60mcg/min infusion Action primarily by venodilation + preload reduction May cause hypotension. Avoid in Aortic Stenosis Circulation

12 Diuretics Mainstay of treatment for 40 + yrs
Primarily useful in volume overload APO Utility in hypertensive diastolic LVF? Postulated to have venodilating and diuretic effect Frusemide should produce diuresis in 15-20mins Diuretics

13 CXR – Confirmatory for diagnosis; exclude other causes of severe dyspnoea
ECG – ACS; arrhythmia FBC – Check for anaemia UEC – Na, K and renal parameters. Consider checking Mg Troponin – ACS ; beware high sensitivity results BNP ?- Clinical APO more sensitive and specific. ABG? – Not required Investigations

14 Challenging scenarios
APO in the Dialysis patient APO with rapid AF APO with hypotension Challenging scenarios

15 APO and the dialysis pt Often true volume overload
Prone to all other causes of LVF however!! Unable to remove salt/H2O Often respond well to NIPPV/nitrates Require emergent transfer to acute dialysis centre/ICU APO and the dialysis pt

16 Check for background history of AF and if rate appropriate
New onset AF requires control Avoid –ve inotrope Amiodarone 5mg/kg q 60min If fails with clinical deteriorationcardioversion Digoxin unlikely to help acutely APO and rapid AF

17 APO and hypotension Potentially = cardiogenic shock
Check to ensure PEEP correct Assess cause and prognosis Senior intervention with Cardiology and ICU STEMI/ACS  Retrieve to Cath. Centre (?Cardiothoracic) Dobutamine mcg/kg/min OR Adrenaline mcg/kg/min Consider early intubation (high risk) APO and hypotension

18 Questions?

19 Summary APO = syndrome, not a diagnosis
APO is due to LV failure which may be either due to systolic or diastolic failure NIPPV improves both oxygenation and cardiac performance Seek precipitating causes and treat Beware the hypotensive APO patient Summary

20


Download ppt "Dyspnoea III – Pulmonary oedema"

Similar presentations


Ads by Google